389 related articles for article (PubMed ID: 28984200)
21. Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells.
Buechner J; Henriksen JR; Haug BH; Tømte E; Flaegstad T; Einvik C
Differentiation; 2011 Jan; 81(1):25-34. PubMed ID: 20980091
[TBL] [Abstract][Full Text] [Related]
22. NGF activation of TrkA decreases N-myc expression via MAPK path leading to a decrease in neuroblastoma cell number.
Woo CW; Lucarelli E; Thiele CJ
Oncogene; 2004 Feb; 23(8):1522-30. PubMed ID: 14691455
[TBL] [Abstract][Full Text] [Related]
23. De novo identification of MIZ-1 (ZBTB17) encoding a MYC-interacting zinc-finger protein as a new favorable neuroblastoma gene.
Ikegaki N; Gotoh T; Kung B; Riceberg JS; Kim DY; Zhao H; Rappaport EF; Hicks SL; Seeger RC; Tang XX
Clin Cancer Res; 2007 Oct; 13(20):6001-9. PubMed ID: 17947461
[TBL] [Abstract][Full Text] [Related]
24. Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis.
Chen Y; Stallings RL
Cancer Res; 2007 Feb; 67(3):976-83. PubMed ID: 17283129
[TBL] [Abstract][Full Text] [Related]
25. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
26. MYC transcription activation mediated by OCT4 as a mechanism of resistance to 13-cisRA-mediated differentiation in neuroblastoma.
Wei SJ; Nguyen TH; Yang IH; Mook DG; Makena MR; Verlekar D; Hindle A; Martinez GM; Yang S; Shimada H; Reynolds CP; Kang MH
Cell Death Dis; 2020 May; 11(5):368. PubMed ID: 32409685
[TBL] [Abstract][Full Text] [Related]
27. SESN1 functions as a new tumor suppressor gene via Toll-like receptor signaling pathway in neuroblastoma.
Hua Z; Chen B; Gong B; Lin M; Ma Y; Li Z
CNS Neurosci Ther; 2024 Mar; 30(3):e14664. PubMed ID: 38516781
[TBL] [Abstract][Full Text] [Related]
28. N-myc gene amplification/expression in localized stroma-rich neuroblastoma (ganglioneuroblastoma).
Fabbretti G; Valenti C; Loda M; Brisigotti M; Cozzutto C; Tonini GP; Callea F
Hum Pathol; 1993 Mar; 24(3):294-7. PubMed ID: 8454274
[TBL] [Abstract][Full Text] [Related]
29. Integrative analysis with machine learning identifies diagnostic and prognostic signatures in neuroblastoma based on differentially DNA methylated enhancers between INSS stage 4 and 4S neuroblastoma.
Li S; Mi T; Jin L; Liu Y; Zhang Z; Wang J; Wu X; Ren C; Wang Z; Kong X; Liu J; Luo J; He D
J Cancer Res Clin Oncol; 2024 Mar; 150(3):148. PubMed ID: 38512513
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of N-myc and c-src proto-oncogenes during neuronal and schwannian differentiation of human neuroblastoma cells.
Horii Y; Sugimoto T; Sawada T; Imanishi J; Tsuboi K; Hatanaka M
Int J Cancer; 1989 Feb; 43(2):305-9. PubMed ID: 2917804
[TBL] [Abstract][Full Text] [Related]
31. A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients.
Fardin P; Barla A; Mosci S; Rosasco L; Verri A; Versteeg R; Caron HN; Molenaar JJ; Ora I; Eva A; Puppo M; Varesio L
Mol Cancer; 2010 Jul; 9():185. PubMed ID: 20624283
[TBL] [Abstract][Full Text] [Related]
32. Repurposing a plant alkaloid homoharringtonine targets insulinoma associated-1 in N-Myc-activated neuroblastoma.
Chen C; Wu J; Hicks C; Lan MS
Cell Signal; 2023 Sep; 109():110753. PubMed ID: 37301315
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of NT5E/CD73 in neuroblastoma and its function in CSC stemness maintenance.
Jain D; Somasundaram DB; Aravindan S; Yu Z; Baker A; Esmaeili A; Aravindan N
Cell Biol Toxicol; 2023 Jun; 39(3):967-989. PubMed ID: 34773529
[TBL] [Abstract][Full Text] [Related]
34. Target Genes of c-MYC and MYCN with Prognostic Power in Neuroblastoma Exhibit Different Expressions during Sympathoadrenal Development.
Yuan Y; Alzrigat M; Rodriguez-Garcia A; Wang X; Bexelius TS; Johnsen JI; Arsenian-Henriksson M; Liaño-Pons J; Bedoya-Reina OC
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760568
[TBL] [Abstract][Full Text] [Related]
35. MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: a molecular portrait of stage 4S.
Bénard J; Raguénez G; Kauffmann A; Valent A; Ripoche H; Joulin V; Job B; Danglot G; Cantais S; Robert T; Terrier-Lacombe MJ; Chassevent A; Koscielny S; Fischer M; Berthold F; Lipinski M; Tursz T; Dessen P; Lazar V; Valteau-Couanet D
Mol Oncol; 2008 Oct; 2(3):261-71. PubMed ID: 19383347
[TBL] [Abstract][Full Text] [Related]
36. Musashi-2 (MSI2) promotes neuroblastoma tumorigenesis through targeting MYC-mediated glucose-6-phosphate dehydrogenase (G6PD) transcriptional activation.
Jiang P; Zhang T; Wu B; Li X; Fu M; Xu B
Med Oncol; 2023 Oct; 40(11):332. PubMed ID: 37843625
[TBL] [Abstract][Full Text] [Related]
37. Bi-modal differentiation pattern in a new human neuroblastoma cell line in vitro.
Matsushima H; Bogenmann E
Int J Cancer; 1992 May; 51(2):250-8. PubMed ID: 1568793
[TBL] [Abstract][Full Text] [Related]
38. Enteric neural crest differentiation in ganglioneuromas implicates Hedgehog signaling in peripheral neuroblastic tumor pathogenesis.
Gershon TR; Shiraz A; Qin LX; Gerald WL; Kenney AM; Cheung NK
PLoS One; 2009 Oct; 4(10):e7491. PubMed ID: 19834598
[TBL] [Abstract][Full Text] [Related]
39. Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex.
Shi Q; Yu B; Zhang Y; Yang Y; Xu C; Zhang M; Chen G; Luo F; Sun B; Yang R; Li Y; Feng H
Cell Oncol (Dordr); 2023 Dec; 46(6):1763-1775. PubMed ID: 37466744
[TBL] [Abstract][Full Text] [Related]
40. N-Myc regulates expression of pluripotency genes in neuroblastoma including lif, klf2, klf4, and lin28b.
Cotterman R; Knoepfler PS
PLoS One; 2009 Jun; 4(6):e5799. PubMed ID: 19495417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
